(2016) Cost components of treatment protocols of haemophilia patients with inhibitors using bypassing agents in Iran. Iranian Journal of Pharmaceutical Sciences. pp. 85-90. ISSN 17352444 (ISSN)

(2016) Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven (TM)) and Activated Prothrombin Complex Concentrates (FEIBA (TM)) to Treat Hemophilia A Patients with Inhibitors in Iran. Iranian Journal of Pharmaceutical Research. pp. 669-677. ISSN 1735-0328

(2014) Comparison of Bypassing Agents in Bleeding Reduction in Treatment of Bleeding Episodes in Patients With Haemophilia and Inhibitors. Iranian Red Crescent Medical Journal. p. 6. ISSN 2074-1804